These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28978084)

  • 1. Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients.
    Zhao JX; Liu LR; Yang XY; Liu F; Zhang ZG
    Oncotarget; 2017 Sep; 8(40):67918-67932. PubMed ID: 28978084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic diagnostic value of circulating tumor cells and tumor markers CEA/CA19-9 in colorectal cancer.
    Cai M; He H; Hong S; Weng J
    Scand J Gastroenterol; 2023 Jan; 58(1):54-60. PubMed ID: 35968572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the polymeric circulating tumor cell chip to capture circulating tumor cells in blood samples of patients with colorectal cancer.
    Kure K; Hosoya M; Ueyama T; Fukaya M; Sugimoto K; Tomiki Y; Ohnaga T; Sakamoto K; Komiyama H
    Oncol Lett; 2020 Mar; 19(3):2286-2294. PubMed ID: 32194728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9.
    Luo S; Ou Y; Zheng T; Jiang H; Wu Y; Zhao J; Zhang Z
    J Oncol; 2021; 2021():1517488. PubMed ID: 34976053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant diagnostic value of circulating tumour cells in colorectal cancer.
    Yu H; Ma L; Zhu Y; Li W; Ding L; Gao H
    Oncol Lett; 2020 Jul; 20(1):317-325. PubMed ID: 32565958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Efficacy of Circulating Tumor Cells in First Drainage Vein Blood from Patients with Colorectal Cancer Liver Metastasis.
    Yang X; Bi X; Liu F; Huang J; Zhang Z
    Cancer Invest; 2022 Oct; 40(9):767-776. PubMed ID: 35797354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker.
    Song BG; Kwon W; Kim H; Lee EM; Han YM; Kim H; Byun Y; Lee KB; Lee KH; Lee KT; Lee JK; Jang JY; Park JK
    Front Oncol; 2020; 10():616440. PubMed ID: 33680936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
    Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
    Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
    Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
    J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer: Does the Seed Leave the Soil Again?
    Rahbari NN; Bork U; Schölch S; Reissfelder C; Thorlund K; Betzler A; Kahlert C; Schneider M; Ulrich AB; Büchler MW; Weitz J; Koch M
    Ann Surg; 2016 Feb; 263(2):345-52. PubMed ID: 26501709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases.
    Tseng JY; Yang CY; Liang SC; Liu RS; Yang SH; Lin JK; Chen YM; Wu YC; Jiang JK; Lin CH
    Clin Cancer Res; 2014 Jun; 20(11):2885-97. PubMed ID: 24677375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer.
    Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Xu H; Wang Z
    BMC Cancer; 2015 Mar; 15():202. PubMed ID: 25880692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
    Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
    Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
    Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
    Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer.
    Zhang Y; Su H; Wang H; Xu C; Zhou S; Zhao J; Shen S; Xu G; Wang L; Zou X; Zhang S; Lv Y
    Cancer Manag Res; 2021; 13():7649-7661. PubMed ID: 34675662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.